Contraceptive activity of a spermicidal aryl phosphate derivative of bromo-methoxy-zidovudine (compound WHI-07) in rabbits

Fertil Steril. 2003 Apr;79(4):864-72. doi: 10.1016/s0015-0282(02)04845-8.

Abstract

Objective: To determine the vaginal contraceptive activity of WHI-07 in the rabbit model.

Design: Prospective, controlled study.

Setting: Center for advanced preclinical sciences.

Animal(s): Subgroups of 15, 16, or 24 New Zealand White does and 24 bucks per experiment.

Intervention(s): Ex vivo (Experiment 1) and in vivo (Experiments 2 and 3) treatment of semen with WHI-07 or Nonoxynol-9 (N-9). In Experiment I, ovulated does in subgroups of 15 were artificially inseminated with semen mixed with WHI-07 or vehicle. In Experiment 2, ovulated does in subgroups of 24 were artificially inseminated within 2 min after intravaginal administration of 2% WHI-07 gel-microemulsion or 2% N-9 gel and allowed to complete term pregnancy. In Experiment 3, ovulated does in subgroups of 16 were artificially inseminated at 15, 30, or 60 minutes.

Main outcome measure(s): The numbers of implanted embryos on postinsemination day 8 or the proportion of does that became pregnant and delivered newborn rabbits; the litter size, weight, growth, and viability of pups until lactation day 5.

Result(s): Exposure of semen to WHI-07 at the time of artificial insemination completely inhibited pregnancy rates (WHI-07-pretreated, 0%, vs. control, 60%) and embryo implantation (WHI-07-pretreated, 0/175 vs. control, 68/170). Intravaginal administration of a 2% WHI-07 gel-microemulsion or 2% N-9 gel before artificial insemination significantly inhibited pregnancy rates (81% and 85% inhibition, respectively) when compared with control. Furthermore, the 2% WHI-07 gel-microemulsion provided >90% inhibition of fertility even when insemination was delayed until 60 minutes after intravaginal application. Rabbits that delivered litters despite intravaginal application of 2% WHI-07 gel-microemulsion had healthy offsprings with no perinatal or postnatal repercussions.

Conclusion(s): WHI-07 is a potent contraceptive agent in vivo. Intravaginal use of WHI-07 gel-microemulsion has clinical potential as a safe prophylactic contraceptive, in addition to its microbicide activity to curb the sexual transmission of HIV.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Intravaginal
  • Animals
  • Dideoxynucleotides
  • Embryo Implantation / drug effects
  • Female
  • Gels / administration & dosage
  • Gels / pharmacology
  • Insemination, Artificial
  • Male
  • Nonoxynol / pharmacology
  • Pregnancy
  • Prospective Studies
  • Rabbits
  • Semen / drug effects
  • Spermatocidal Agents / administration & dosage
  • Spermatocidal Agents / pharmacology*
  • Spermatozoa / metabolism
  • Thymidine Monophosphate / administration & dosage
  • Thymidine Monophosphate / analogs & derivatives*
  • Thymidine Monophosphate / pharmacology*
  • Zidovudine / administration & dosage
  • Zidovudine / analogs & derivatives*
  • Zidovudine / pharmacology*

Substances

  • 5-bromo-6-methoxy-5, 6-dihydro-3'-azidothymidine-5'-(p-bromophenyl) methoxyalaninyl phosphate
  • Dideoxynucleotides
  • Gels
  • Spermatocidal Agents
  • Nonoxynol
  • Thymidine Monophosphate
  • Zidovudine